Anaplastic Oligodendroglioma — Trials

Anaplastic Oligodendroglioma — Trials · CancerIndex

Clinical trials

Registered studies

100 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 18%
Top sponsor: Children's Oncology Group
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (26)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02055196	Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas	withdrawn	Phase 1	0	City of Hope Medical CenterOTHER	1	Jun 2, 2014	clinicaltrials
NCT00734864	Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma	withdrawn	Phase 1	0	Annick DesjardinsOTHER	1	Nov 21, 2012	clinicaltrials